Infections

Urine Trouble: Should We Think Differently About UTI? - Beyond the Abstract January 18, 2018

Dalfampridine does not increase the risk of urinary tract infections in patients with multiple sclerosis - Beyond the Abstract October 14, 2015

Evaluation of efficacy and tolerability of cefotaxime and sulbactam versus cefepime and tazobactam in patients of urinary tract infection-a prospective comparative study - Beyond the Abstract July 23, 2015

Ultrasonography findings and blood CRP levels can predict the outcomes of VCG after the first UTI in children - Beyond the Abstract July 16, 2015

Bladder volume at onset of vesicoureteral reflux is an independent risk factor for breakthrough febrile urinary tract infection, "Beyond the Abstract," by Christopher S. Cooper, MD, FACS, FAAP June 15, 2015

Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea, "Beyond the Abstract," by Mi-Ran Seo and Hyunjoo Pai June 12, 2015

Predictive factors for kidney damage in febrile urinary tract infection. Usefulness of procalcitonin, "Beyond the Abstract," by Elena Lucas Sáez June 11, 2015

Revisiting the use of ‘forgotten’ drugs such as methenamine, a urinary antiseptic agent, in preventing recurrent urinary tract infections, "Beyond the Abstract," by Kimberly D. Hammer, PhD February 20, 2015

Development and validation of a nomogram for recurrence risk predicting in women with symptomatic UTI: The Lower Urinary Tract Infections Recurrence Risk (LUTIRE) nomogram, "Beyond the Abstract," by Tommaso Cai and Truls E. Bjerklund Johansen February 18, 2015

Poor clinical and economic outcomes with urinary tract infection due to extended-spectrum β-lactamase-producing organisms, "Beyond the Abstract," by Shawn H. MacVane, PharmD, BCPS and David P. Nicolau, PharmD, FCCP, FIDSA August 28, 2014

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections, "Beyond the Abstract," by Filip Jansåker and Niels Frimodt-Møller June 12, 2014

Clinical characteristics predicting early clinical failure after 72 hours of antibiotic treatment in women with community-onset acute pyelonephritis, "Beyond the Abstract," by Hyunjoo Pai, MD, PhD May 30, 2014

Prevalence and risk factors for renal scars in children with febrile UTI and/or vesicoureteral reflux, "Beyond the Abstract," by Nicol Corbin Bush, MD, MSc April 10, 2014

Electrokinetic stringency control in self-assembled monolayer-based biosensors for multiplex urinary tract infection diagnosis, "Beyond the Abstract," by Joseph C. Liao and Pak Kin Wong March 25, 2014

Performance of flow cytometry to screen urine for bacteria and white blood cells prior to urine culture, "Beyond the Abstract," by Callen Giessen and John C. Lieske, MD February 10, 2014

The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens, "Beyond the Abstract," by Casper D.J. den Heijer, PhD, et al January 8, 2014

Antibiotic prophylaxis for urinary tract infections in antenatal hydronephrosis, "Beyond the Abstract," by Rahul K. Bansal, MBBS, MS, MCh and Luis H. Braga, MD, MSc, PhD October 15, 2013

Lifetime reduction in UTI risk by male circumcision, "Beyond the Abstract," by Brian J. Morris, DSc, PhD, FAHA August 27, 2013

A post-hoc analysis suggests that pravastatin can reduce the risk of recurrent urinary tract infections (UTIs), "Beyond the Abstract," by Koen Pouwels, MSc and Eelko Hak, PhD July 15, 2013

A 4-year retrospective study, in adult patients, of the prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection, "Beyond the Abstract," by Kimberly B. Ulett, MD July 1, 2013

Page 1 of 2

Pelvic Health Weekly Newsletter